16.26
0.19 (1.18%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Enliven Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 3.5 |
| 内部交易活动 | -3.5 |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | 0.20 |
|
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven’s programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 6.42% |
| 机构持股比例 | 102.64% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Orbimed Advisors Llc | 31 Dec 2024 | 7,959,538 |
| Commodore Capital Lp | 31 Dec 2024 | 4,205,000 |
| Vr Adviser, Llc | 31 Dec 2024 | 4,026,331 |
| Fairmount Funds Management Llc | 31 Dec 2024 | 3,202,798 |
| 5Am Venture Management, Llc | 31 Dec 2024 | 1,629,765 |
| Ra Capital Management, L.P. | 31 Dec 2024 | 848,986 |
| 52周波幅 | ||
| 中 | 39.00 (139.85%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 21 Mar 2025 | 39.00 (139.85%) | 购买 | 21.08 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| HOHL BENJAMIN | - | 18.91 | -3,250 | -61,458 |
| KINTZ SAMUEL | - | 18.65 | -7,500 | -139,875 |
| LYSSIKATOS JOSEPH P | - | 18.65 | -7,500 | -139,875 |
| 累积净数量 | -18,250 | |||
| 累积净值 ($) | -341,208 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 18.70 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| KINTZ SAMUEL | 职员 | 02 May 2025 | 自动卖出 (-) | 2,170 | 18.65 | 40,471 |
| LYSSIKATOS JOSEPH P | 职员 | 02 May 2025 | 自动卖出 (-) | 2,470 | 18.65 | 46,066 |
| KINTZ SAMUEL | 职员 | 01 May 2025 | 自动卖出 (-) | 5,330 | 18.65 | 99,405 |
| LYSSIKATOS JOSEPH P | 职员 | 01 May 2025 | 自动卖出 (-) | 5,030 | 18.65 | 93,810 |
| HOHL BENJAMIN | 职员 | 28 Apr 2025 | 自动卖出 (-) | 3,250 | 18.91 | 61,458 |
| HOHL BENJAMIN | 职员 | 28 Apr 2025 | 执行期权 | 3,250 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合